会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Anthrax antitoxins
    • 炭疽毒素
    • US07749517B2
    • 2010-07-06
    • US11340424
    • 2006-01-26
    • John A. YoungHeather M. ScobieG. Jonah A. RaineyKenneth A. Bradley
    • John A. YoungHeather M. ScobieG. Jonah A. RaineyKenneth A. Bradley
    • A61K39/07C07H21/04
    • C07K16/1278A61K38/00C07K14/705C07K14/78
    • The present invention provides compositions useful in preparing and/or serving as antitoxins against Bacillus anthracis, the causative agent of anthrax. The present invention also provides polypeptides and polynucleotides relating to the capillary morphogenisis gene 2 (CMG-2), vectors containing the polynucleotides and polypeptides, and host cells containing related polynucleotide molecules, all used in association with the treatment of, or the research and development of treatments for anthrax. The present invention also relates to methods for identifying molecules that bind CMG-2 and molecules that reduce the toxicity of anthrax toxin. Finally, the present invention provides methods for treating human and non-human animals suffering from anthrax.
    • 本发明提供了可用于制备和/或用作抗炭疽杆菌(Anthracis)的抗毒素的组合物,炭疽芽孢杆菌的致病因子。 本发明还提供了与毛细血管形成形成发生基因2(CMG-2)相关的多肽和多核苷酸,含有多核苷酸和多肽的载体以及含有相关多核苷酸分子的宿主细胞,所有这些都与治疗或研究和开发相结合 的炭疽治疗。 本发明还涉及用于鉴定结合CMG-2的分子和降低炭疽毒素毒性的分子的方法。 最后,本发明提供了治疗患有炭疽的人类和非人类动物的方法。